JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report)’s stock price fell 10% during mid-day trading on Monday . The stock traded as low as $4.50 and last traded at $4.50. 200 shares were traded during mid-day trading, a decline of 60% from the average session volume of 500 shares. The stock had previously closed at $5.00.
JCR Pharmaceuticals Stock Down 10.0%
The company has a 50 day moving average price of $4.58 and a 200-day moving average price of $4.50.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.
Featured Stories
- Five stocks we like better than JCR Pharmaceuticals
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 High-Yield Banks for Investors to Buy on the Dip
- What is the NASDAQ Stock Exchange?
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
